PLTR Price Prediction: $196 or $170 — The AI Sovereignty Trade Is At a Crossroads

Palantir sits at $190.05 with MACD momentum flatlined and institutional investors growing cautious, but the Q2 earnings story — 93% revenue growth, $3.4B in bookings — is still live. Bulls push for...

At $190.05 this morning, Palantir is down 1.23% on the session and pressing the underside of a congested resistance band that begins at $193.14 and hardens into a brick wall at $196.23. The 24-hour range of $189.14 to $194.23 tells the whole story: buyers are running right into that zone and getting turned back. The daily candle is effectively printing a bearish hangman against the top of its Bollinger Band expansion — and in a stock that just ripped 60%+ off June lows, that matters.

The catalyst underpinning this rally has been Palantir's Q2 FY2026 print, which was nothing short of explosive. Revenue surged 93% year-over-year to $1.94 billion, blowing past estimates of $1.81 billion. U.S. commercial revenue jumped 149% to $764 million, and the company booked a record $2.13 billion in U.S. commercial contract value in a single quarter. Then came AIPCon11 on September 10, where CEO Alex Karp doubled down on the "AI sovereignty" thesis — the idea that enterprises need to control their own AI infrastructure rather than remain dependent on model providers. UBS and DA Davidson both lifted their price targets to $250 following that event. That narrative is live, and Blockchain.news has been tracking the AI sovereignty theme as one of the defining equity stories of the back half of 2026. But narrative and price action are now diverging, and that's the friction traders need to trade around right now.

The immediate risk is real: a £330 million NHS contract in Britain faces a review clause expiring in February 2027, with lobbyists actively pushing Britain's new government to trigger the break provision. Palantir's domestic growth story dwarfs this exposure — $809 million in U.S. government revenue alone in Q2 — but headline risk from international contract disputes has a habit of rattling even fundamentally sound growth stocks.

Every moving average beneath this stock is trending higher — the 7-day SMA at $187.02, the 20-day and 50-day SMA both converging at $177.09, and the 200-day SMA anchored at $147.36. That structure screams a clean, intact uptrend with significant cushion. The problem is what's happening at the top of the range.

At 88% of the way up the Bollinger Band, PLTR is stretched. It hasn't been at the lower band since the summer lows. Momentum, measured through the MACD, has hit a zero-histogram read — the signal line and the MACD line are effectively sitting on top of each other. That's not a bearish reversal signal in isolation, but it confirms that the engine that drove this stock from $125 to $207.52 is now idling. RSI at 66 keeps bulls technically alive — it's not in overbought territory — but it's pushing the upper boundary of the neutral zone and hasn't got the same runway it did off the August lows.

The Stochastic %K at 84.89 with %D at 67.91 is the more pointed warning. When %K is crossing or approaching %D from above in the upper zone, short-term selling pressure typically follows. Add to this the positioning data: retail is heavily short at a 63.5% short ratio, while smart money — top traders — are sitting at 59.5% short. When both retail and institutional traders are leaning the same direction, the contrarian in you wants to fade them, but the chart structure here is offering them legitimate cover.

Support is well-defined. Immediate floor at $188.05, with strong support at $186.05 just below. A breach of $186 opens a deeper move toward $177, where the confluence of the 20-day and 50-day SMAs sits as the natural corrective target. An ATR of $5.35 means the stock can eat through those levels in two or three sessions of determined selling.

Here is where PLTR's story gets genuinely uncomfortable. The stock trades at a trailing P/E of roughly 152x and a forward P/E of 79x. Against a market cap of approximately $460 billion at current prices, the company is trading at over 74x trailing sales. Analysts polled by S&P Global project full-year 2026 revenue of approximately $8.19 billion — growth of roughly 83% — and FY2027 revenue of $12.21 billion. EPS is forecast at $1.61 for FY2026 and $2.32 for FY2027. That's a genuinely staggering growth profile, and it's real: the numbers are verified, the contracts are public, and the Rule of 40 score of 155% puts Palantir in a league occupied by almost no other software company.

But even the bull camp must acknowledge what 79x forward earnings demands. It demands flawless execution. It demands that U.S. commercial revenue — which accelerated to 149% YoY growth last quarter — doesn't decelerate meaningfully in Q3 2026 results, due in early November. It demands that net dollar retention stays elevated and that those $5.6 billion infrastructure commitments translate into recognized revenue. Any of those metrics softening will trigger a violent multiple compression, not just a modest pullback.

Hourly candlesticks (about 96 bars), same endpoint as our cryptocurrency price pages. Numbers below refresh from 1-minute klines.